Venture Teams

Accure Health

Accure Health develops and integrates miniaturized biosensor technologies and digital healthcare solutions to enable fast, cost-effective and highly accurate cancer diagnosis in ...

Day Zero Diagnostics

Antibiotic resistance prediction using whole genome sequencing for fast diagnosis of bacterial infections.


At DeepBiome, we have a different vision for drug discovery. Digital. Scalable. Automatable. The future of pharma is nothing like the status quo.

Elevian Inc.

Elevian develops therapeutics that stimulate regenerative capacity, to treat and prevent the diseases of aging.

GRO Biosciences

GRO Bio produces high-value protein therapeutics in microbes that must traditionally be made in expensive mammalian systems. Using our proprietary genomically recoded organisms (GROs), ...

i2O Therapeutics

i2O Therapeutics is a drug delivery company developing safe and effective oral formulations of therapies traditionally limited to injections.

Metalmark Innovations

Metalmark develops novel materials for the catalytic decomposition of air pollutants in order to make clean air globally accessible and affordable.

Molecular Loop Biosciences, Inc.

Molecular Loop is commercializing a technology to accelerate basic genomics research and expand access to clinical and consumer genetic information.


Pioneering a novel, proprietary, eco-friendly process of upcycling plastic waste into valuable products for consumers and environmental remediation.

Octagon Therapeutics

Octagon is developing targeted therapies that block the proliferation of disease-causing cells. Current efforts are focused on programs in autoimmune disease and bacterial infection.


PlateletDiagnostics’ goal is to improve patient care by creating reliable, inexpensive diagnostics that rapidly and inexpensively assess platelet function.


Leveraging bacterial genetic engineering to serve patients with orphan diseases of the alimentary tract.